MedTrace Logo

To Evaluate the Therapeutic Equivalence and Safety of Azelaic Acid 15% Topical Gel

NCT03094403 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2024-04-10

No results posted yet for this study

Summary

A Multi-Center, Double-Blind, Randomized, Placebo Controlled, Parallel-Group Study

Conditions

  • Rosacea

Interventions

DRUG

Azelaic Acid 15% topical gel

Gel

DRUG

Finacea® (azelaic acid) Gel, 15%

Gel

DRUG

Placebo

Gel

Sponsors & Collaborators

  • Sun Pharmaceutical Industries, Inc.

    lead INDUSTRY

Principal Investigators

  • Catawba Research · http://catawbaresearch.com/contact/

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-07-01
Primary Completion
2017-03-31
Completion
2017-04-01
FDA Drug
Yes

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03094403 on ClinicalTrials.gov